Press Releases

Gilead Sciences to Present at Two Upcoming Investor Conferences

- Jefferies 2012 Global Healthcare Conference on June 5th -
- Goldman Sachs 33rd Annual Global Healthcare Conference on June 6th -
- Webcasts Available Through Gilead Corporate Website -

FOSTER CITY, Calif.--(BUSINESS WIRE)--May. 29, 2012-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the Jefferies Global Healthcare Conference in New York and the Goldman Sachs Healthcare Conference in Rancho Palos Verdes, California.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, and Robin Washington, Gilead’s Senior Vice President and Chief Financial Officer, will provide an overview of the company at the Jefferies conference on Tuesday, June 5 at 10:30 a.m. Eastern Time and the Goldman Sachs conference on Wednesday, June 6 at 9:20 a.m. Pacific Time (12:20 p.m. Eastern Time).

To access the live webcasts via the Internet log on to Please connect to the company’s website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936 (Investor Relations)